• Travere Therapeutics granted inducement restricted stock units covering 65,520 common shares to 20 new employees on November 10, 2026.
• The awards vest over four years, with 25% vesting on each grant-date anniversary, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Travere Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611121700BIZWIRE_USPR_____20261112_BW057427) on November 12, 2026, and is solely responsible for the information contained therein.